ActHIB
NDC 49281-545, HAEMOPHILUS INFLUENZAE TYPE B STRAIN 1482 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, kit, from Sanofi Vaccines US Inc..
- Product NDC
- 49281-545
- Status
- Listed
- Labeler
- Sanofi Vaccines US Inc.
- Dosage form
- KIT
- Route
- —
- Product type
- VACCINE
- Marketing category
- BLA
- Application
- BLA103935
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/49281-545 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
None listed.
| Package NDC | NDC-11 | Package |
|---|---|---|
| 49281-545-03 | 49281054503 | 1 KIT in 1 CARTON (49281-545-03) * .6 mL in 1 VIAL, SINGLE-DOSE (49281-546-58) * .5 mL in 1 VIAL, SINGLE-DOSE (49281-547-58) |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 49281-545 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/49281-545 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 49281-545. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.